deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT02393040

Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia (PRP)

A Prospective Double Blind, Placebo Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

Sponsor: Universitat Internacional de Catalunya

Interventions PRP/Saline
Updated 6 times since 2017 Last updated: Mar 18, 2015 Started: Jan 31, 2014 Primary completion: Jul 31, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alopecia and Androgenetic Alopecia and is currently ongoing. Universitat Internacional de Catalunya leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. May 2017 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

Show 1 earlier version
  1. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universitat Internacional de Catalunya
Data source: Universitat Internacional de Catalunya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations